Point of care testing of biochemical markers for monitoring astronauts during long duration missions in deep space
Clinical laboratory capabilities on the ISS are currently minimal. As missions lengthen, and extend beyond LEO, enhanced POCT is needed. Limited data on POCT performance in space highlight the importance of laboratory professionals' involvement to ensure high-quality testing and accurate interpretation.
Authors
- Simona Ferraro (ORCID: https://orcid.org/0000-0002-6733-4166)
- Julie Shaw (ORCID: https://orcid.org/0000-0003-3983-8487)
- Maurizio Cheli (ORCID: https://orcid.org/0000-0003-1953-278X)
- Anilkumar Dave
- Santica M. Marcovina (ORCID: https://orcid.org/0000-0002-9118-8488)
- Gianvincenzo Zuccotti (ORCID: https://orcid.org/0000-0002-2795-9874)
- Rafael A. Colon
- Christopher E. Mason (ORCID: https://orcid.org/0000-0002-1850-1642)
- Sohini Sengupta (ORCID: https://orcid.org/0000-0001-7291-829X)
Institutions
- Medpace (United States) (US)
- Prince Sattam Bin Abdulaziz University (SA)
- University of Milan (IT)
- Cornell University (US)
- Quantitative BioSciences (US)
- Population Services International (IN)
- Canadian Electricity Association (CA)
- Institute of Space and Astronautical Science (JP)
- Ospedale dei Bambini Vittore Buzzi (IT)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1515/cclm-2025-0526
- Primary Topic
- Spaceflight effects on biology
- Type
- article
- Field-Weighted Citation Impact
- 0.00